Clinical Trial Update: A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease [Phase 1]

View source ↗

Summary

A Phase 1 open-label study evaluating the effect of food on SEN0014196 in subjects with Huntington's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• SEN0014196

Snippet

Sponsor: Siena Biotech S.p.A. | Conditions: Huntington's Disease | Phase 1 | Status: COMPLETED